Epileptic syndromes in children with cerebral palsy

by T. T. Batysheva, A. N. Platonova, O. V. Bykova
Published 2016-08-01

Microbial eczema: up-to-date topical treatment with silver sulfathiazole

by A. L. Bakulev, S. S. Kravchenya, A. N. Platonova
Published 2017-08-01

INTERFERON BETA IN TREATMENT OF DISSEMINATED SCLEROSIS IN ADOLESCENTS — INFLUENCE ON NEUROPSYCHOLOGICAL STATUS AND PAROXYSMAL STATES

by A.N. Platonova, L.M. Kuzenkova, O.V. Bykova
Published 2010-07-01

INTERFERON BETA IN TREATMENT OF DISSEMINATED SCLEROSIS IN ADOLESCENTS — INFLUENCE ON NEUROPSYCHOLOGICAL STATUS AND PAROXYSMAL STATES

by A.N. Platonova, L.M. Kuzenkova, O.V. Bykova
Published 2010-01-01

Long-term therapy of severe acne: selection of doses and administration schemes for systemic isotretinoin

by A. L. Bakulev, S. S. Kravchenya, A. N. Platonova, I. A. Igonina
Published 2017-08-01

QUALITY OF LIFE IN ADOLESCENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA-1A FOR SUBCUTANEOUS INJECTION

by A.N. Platonova, O.V. Bykova, I.V. Vinyarskaya, L.M. Kuzenkova
Published 2009-03-01

QUALITY OF LIFE IN ADOLESCENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA-1A FOR SUBCUTANEOUS INJECTION

by A.N. Platonova, O.V. Bykova, I.V. Vinyarskaya, L.M. Kuzenkova
Published 2009-01-01

Endothelial dysfunction and its treatment in psoriasis patients

by Yu. M. Shtoda, N. A. Slesarenko, A. L. Bakulev, S. R. Utz, A. N. Platonova
Published 2017-08-01

CLINICALLY ISOLATED SYNDROME IN CHILDREN AND ADOLESCENTS — RISK FACTORS FOR MULTIPLE SCLEROSIS AND PROSPECTS OF USING INTRAMUSCULAR INTERFERON β-1A

by O.V. Bykova, A.N. Platonova, N.N. Shatilova, A.V. Anikin, L.M. Kuzenkova
Published 2010-05-01

CLINICALLY ISOLATED SYNDROME IN CHILDREN AND ADOLESCENTS — RISK FACTORS FOR MULTIPLE SCLEROSIS AND PROSPECTS OF USING INTRAMUSCULAR INTERFERON β-1A

by O.V. Bykova, A.N. Platonova, N.N. Shatilova, A.V. Anikin, L.M. Kuzenkova
Published 2010-05-01

SAFETY OF INTERFERON BETA 1A FOR A SUBCUTANEOUS ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH DISSEMINATED SCLEROSIS

by O.V. Bykova, A.N. Platonova, N.V. Gol'tsova, L.M. Kuzenkova, A.N. Boiko
Published 2008-06-01

SAFETY OF INTERFERON BETA 1A FOR A SUBCUTANEOUS ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH DISSEMINATED SCLEROSIS

by O.V. Bykova, A.N. Platonova, N.V. Gol'tsova, L.M. Kuzenkova, A.N. Boiko
Published 2008-01-01

EARLY DIFFERENTIAL DIAGNOSTICS AND PROLONGED IMMUNOMODULATORY THERAPY OF CHRONIC INFLAMMATORY DEMYELINATING DISEASES OF CENTRAL NERVOUS SYSTEM IN CHILDREN AND ADOLESCENTS

by O.V. Bykova, A.N. Platonova, N.V. Gol'tsova, G.V. Kuznetsova, L.M. Kuzenkova, A.N. Boiko
Published 2009-11-01

USE OF INTERFERON BETA-1A FOR INTRAMUSCULAR ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH MULTIPLE SCLEROSIS: EFFICACY, SAFETY AND ADHERENCE TO THERAPY

by O.V. Bykova, T.V. Sidorenko, A.N. Platonova, N.V. Gol’tsova, L.M. Kuzenkova, A.N. Boiko
Published 2009-10-01

USE OF INTERFERON BETA-1A FOR INTRAMUSCULAR ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH MULTIPLE SCLEROSIS: EFFICACY, SAFETY AND ADHERENCE TO THERAPY

by O.V. Bykova, T.V. Sidorenko, A.N. Platonova, N.V. Gol’tsova, L.M. Kuzenkova, A.N. Boiko
Published 2009-10-01

EARLY DIFFERENTIAL DIAGNOSTICS AND PROLONGED IMMUNOMODULATORY THERAPY OF CHRONIC INFLAMMATORY DEMYELINATING DISEASES OF CENTRAL NERVOUS SYSTEM IN CHILDREN AND ADOLESCENTS

by O.V. Bykova, A.N. Platonova, N.V. Gol'tsova, G.V. Kuznetsova, L.M. Kuzenkova, A.N. Boiko
Published 2009-01-01